
Loading, please wait...

Loading, please wait...

A systematic review and meta-analysis of randomized and observational studies compared surgical with conservative treatment for cervical spondylotic myelopathy. Although postoperative JOA scores were not uniformly different between groups, the surgical group showed greater improvement and a higher recovery rate overall. The findings suggest that surgery may provide more neurological recovery in appropriate patients, while also showing how differences in baseline severity and study design can influence conclusions. For HCPs, the paper is best used to frame rather than dictate treatment. Patients with progressive or clinically meaningful myelopathy may gain from decompression, but the magnitude of benefit depends on disease severity, duration and individual anatomy. Conservative treatment may still be reasonable for mild, stable cases under close observation. The evidence also highlights the limits of pooled observational data, especially when surgical patients begin with more severe disease. A careful neurological examination remains essential, and treatment should be based on clinical progression rather than imaging severity alone. The practical message is to combine patient phenotype, trajectory and evidence quality when discussing the timing of cervical decompression.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review and meta-analysis of randomized and observational studies compared surgical with conservative treatment for cervical spondylotic myelopathy. Although postoperative JOA scores were not uniformly different between groups, the surgical group showed greater improvement and a higher recovery rate overall. The findings suggest that surgery may provide more neurological recovery in appropriate patients, while also showing how differences in baseline severity and study design can influence conclusions. For HCPs, the paper is best used to frame rather than dictate treatment. Patients with progressive or clinically meaningful myelopathy may gain from decompression, but the magnitude of benefit depends on disease severity, duration and individual anatomy. Conservative treatment may still be reasonable for mild, stable cases under close observation. The evidence also highlights the limits of pooled observational data, especially when surgical patients begin with more severe disease. A careful neurological examination remains essential, and treatment should be based on clinical progression rather than imaging severity alone. The practical message is to combine patient phenotype, trajectory and evidence quality when discussing the timing of cervical decompression.
4 weeks back

Discover how catalytic nanozymes redefine autoimmune disease therapy by establishing a physiological redox set-point to restore immune tolerance without broad immunosuppression.
Last week

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back

A landmark comparative study evaluates atrial electrophysiology across humans, swine, and rodents. By linking cellular recordings with transcriptomics and in silico modeling, researchers resolve cross-species gaps, explaining translational failures to advance targeted therapies for atrial arrhythmias.
3 weeks back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
last month

Researchers have developed an innovative ultrasound-responsive nano-contrast agent that co-delivers CIITA-siRNA and rapamycin directly to inflamed thyroid tissue, significantly reducing autoimmune injury and thyroid autoantibodies in preclinical models of Hashimoto thyroiditis.
3 weeks back